Posts in tag

PBAC


Pharmacy group estimates average loss of $85k in gross profit per pharmacy if 60-day dispensing proposal goes forward With the 60-day dispensing proposal still on the table, the Rural Pharmacy …

Decision on PPI double dosing deferred by PBAC, but support given to antibiotic listing changes The Pharmaceutical Benefits Advisory Committee (PBAC) has deferred a decision on whether to allow twice …

Are two month prescriptions back on the government’s agenda? Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) that prescription lengths be doubled to two months for a range of medicines …

PBAC reveals the latest raft of new recommendations made on PBS drugs The latest recommendations made by the Pharmaceutical Benefits Advisory Committee have been released, with new listings for naloxone …

Nine new blockbuster drugs headed our way soon: report A series of new ‘blockbuster’ drugs are expected to hit Australian shores in the next 12-24 months, a new report claims. …

An HIV prevention advocate has vowed to keep fighting for pre exposure prophylaxis to be PBS listed Following the announcement by the Pharmaceutical Benefits Advisory Committee that it will defer …

Consumers’ group deputy head now gains a senior role on key PBS committee Federal Health Minister Greg Hunt has announced that Jo Watson, deputy chair of the Consumers Health Forum …

A higher than usual degree of pharmacovigilance is required when patients are switched to new biosimilar medications, say Australian experts Writing in the latest Australian Prescriber two pharmacy academics have stressed …

But NOACs have contributed to an overall growth in the anticoagulant market Based on the volume of prescriptions, use of novel oral anticoagulants (NOACs) in Australia has grown since their …

Stakeholders have expressed disappointment in the PBAC’s restatement of its decision to delist Panadol Osteo, and concerns that patients may turn to stronger alternatives to manage their pain. The PBAC …

It is time the government ‘fessed up’ that Panadol Osteo has been de-listed from the PBS by mistake, says the Guild today. It says that in April last year PBAC set very clear criteria …

It is the first time Health Minister Sussan Ley has referred a company to the ACCC due to the “unique” circumstances surrounding the price rise for Panadol Osteo, a spokesman for …